Zim Laboratories (NSE:ZIMLAB) Other Long-Term Liabilities : ₹111 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Zim Laboratories Other Long-Term Liabilities?

Zim Laboratories's other long-term liabilities for the quarter that ended in Mar. 2025 was ₹111 Mil.

Zim Laboratories's quarterly other long-term liabilities declined from Sep. 2024 (₹139 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹111 Mil).

Zim Laboratories's annual other long-term liabilities increased from Mar. 2023 (₹48 Mil) to Mar. 2024 (₹101 Mil) and increased from Mar. 2024 (₹101 Mil) to Mar. 2025 (₹111 Mil).

Zim Laboratories Other Long-Term Liabilities Historical Data

The historical data trend for Zim Laboratories's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zim Laboratories Other Long-Term Liabilities Chart

Zim Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Other Long-Term Liabilities

Get a 7-Day Free Trial

3.63

48.03

101.01

110.50

Zim Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															101.01	-	139.42	-	110.50

Zim Laboratories Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Zim Laboratories Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Zim Laboratories's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zim Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zim Laboratories Ltd (NSE:ZIMLAB) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

541400:India

Address

Nelson Square, Chhindwara Road, Sadoday Gyan, Ground Floor, Opposite NADT, Nagpur, MH, IND, 440 013

Website

https://www.zimlab.in

Zim Laboratories Ltd is a pharmaceutical company. The company is mainly engaged in the manufacturing of formulation drugs and pre-formulation ingredients. Geographically, the group has a business presence in India and other countries, of which key revenue is derived from Outside India. The products offered by the company are Ondansetron, Melatonin, Nicotine, Vitamin D3, and others. The majority of its revenue is derived from the sale of pharmaceutical goods.

Zim Laboratories Headlines

No Headlines